AOXG | Aoxing Pharmaceutical Company, Inc. Annual &

Annual Balance Sheets

(In USD)

Breakdown	2023	2022	2021	2020	2019	2016
Total Assets	-	-	-	-	-	56.23 Million
Total Current Assets	-	-	-	-	-	26.86 Million
Cash And Short Term Investments	-	-	-	-	-	6.91 Million
Cash and Cash Equivalents	-	-	-	-	-	6.91 Million
Short Term Investments	-	-	-	-	-	-
Net Receivables	-	-	-	-	-	11.2 Million
Inventory	-	-	-	-	-	2.84 Million
Other Current Assets	-	-	-	-	-	5.91 Million
Total Non-Current Assets	-	-	-	-	-	29.36 Million
Net PPE	-	-	-	-	-	25.6 Million
Good Will And Intangible Assets	-	-	-	-	-	1.87 Million
Good Will	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	1.87 Million
Long-Term Investments	-	-	-	-	-	4200.00
Tax Assets	-	-	-	-	-	1.87 Million
Other Non Current Assets	-	-	-	-	-	-
Other Assets	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	38.15 Million
Total Current Liabilities	-	-	-	-	-	37.81 Million
Account Payables	-	-	-	-	-	2.7 Million
Tax Payables	-	-	-	-	-	2.61 Million
Short Term Debt	-	-	-	-	-	25.47 Million
Deferred Revenue	-	-	-	-	-	413.84 Thousand
Other Current Liabilities	-	-	-	-	-	9.21 Million
Total Non Current Liabilities	-	-	-	-	-	340.08 Thousand
Long-Term Debt	-	-	-	-	-	-
Deferred Revenue Non Current	-	-	-	-	-	340.08 Thousand
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	-	-	-	-	-	-
Other Liabilities	-	-	-	-	-	-
Total Equity	-	-	-	-	-	18.07 Million
Stock Holders Equity	-	-	-	-	-	19.13 Million
Common Stock	-	-	-	-	-	76.2 Thousand
Retained Earnings	-	-	-	-	-	-56.29 Million
Accumulated other comprehensive income	-	-	-	-	-	1.72 Million
Common Stock Equity	-	-	-	-	-	19.13 Million
Capital Lease Obligation	-	-	-	-	-	-
Total Investments	-	-	-	-	-	4200.00
Total Debt	-	-	-	-	-	25.47 Million
Net Debt	-	-	-	-	-	18.55 Million

Breakdown	2022 FY	2021 FY	2020 FY	2019 FY	2018 FY	2016 Q3
Total Assets	-	-	-	-	-	62.46 Million
Total Current Assets	-	-	-	-	-	34.8 Million
Cash And Short Term Investments	-	-	-	-	-	7.08 Million
Cash and Cash Equivalents	-	-	-	-	-	7.08 Million
Short Term Investments	-	-	-	-	-	-
Net Receivables	-	-	-	-	-	15.28 Million
Inventory	-	-	-	-	-	2.4 Million
Other Current Assets	-	-	-	-	-	10.02 Million
Total Non-Current Assets	-	-	-	-	-	27.66 Million
Net PPE	-	-	-	-	-	24.03 Million
Good Will And Intangible Assets	-	-	-	-	-	1.79 Million
Good Will	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	1.79 Million
Long-Term Investments	-	-	-	-	-	-1826.27
Tax Assets	-	-	-	-	-	1.82 Million
Other Non Current Assets	-	-	-	-	-	1826.27
Other Assets	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	44.38 Million
Total Current Liabilities	-	-	-	-	-	43.97 Million
Account Payables	-	-	-	-	-	4.93 Million
Tax Payables	-	-	-	-	-	3.44 Million
Short Term Debt	-	-	-	-	-	27.62 Million
Deferred Revenue	-	-	-	-	-	261.71 Thousand
Other Current Liabilities	-	-	-	-	-	11.14 Million
Total Non Current Liabilities	-	-	-	-	-	409.52 Thousand
Long-Term Debt	-	-	-	-	-	100.12 Thousand
Deferred Revenue Non Current	-	-	-	-	-	309.4 Thousand
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	-	-	-	-	-	309.40
Other Liabilities	-	-	-	-	-	-
Total Equity	-	-	-	-	-	18.08 Million
Stock Holders Equity	-	-	-	-	-	19.1 Million
Common Stock	-	-	-	-	-	76.2 Thousand
Retained Earnings	-	-	-	-	-	-55.85 Million
Accumulated other comprehensive income	-	-	-	-	-	1.24 Million
Common Stock Equity	-	-	-	-	-	19.1 Million
Capital Lease Obligation	-	-	-	-	-	-
Total Investments	-	-	-	-	-	-1826.27
Total Debt	-	-	-	-	-	27.72 Million
Net Debt	-	-	-	-	-	20.64 Million